What is GLSHQ's gross margin?

Gelesis (GLSHQ) has a gross margin of 55% and a net margin of -694%.

What is GLSHQ's P/E ratio?

Track Gelesis (GLSHQ) P/E ratio, ROE, and valuation metrics over time.

Where can I see GLSHQ's full financials?

See Gelesis (GLSHQ) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Gelesis (GLSHQ) Financials — Revenue, Earnings, Cash Flow

Also trades as: GLS (NYSE) · $vol 0M · GLS-WT (NYSE) · $vol 0M

$0.00

+0.00 (+0.00%)

OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 51 · $7334 mcap · 35M float · 0.0006% daily turnover · Short 7% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$12M

Revenue

-45.8% YoY

$-52M

Net Income

+24.7% YoY

$-50M

Free Cash Flow

+32.6% YoY

55.0%

Gross Margin

-903.0%

Op. Margin

-693.9%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE391.0%

ROA-44.0%

ROIC-233.6%

Valuation

P/E-0.0

P/B-0.0

EV/EBITDA-1.4

Leverage

Debt/Equity-1.96

Current Ratio0.32

Interest Cov.-22.5x

Quality Scores

Piotroski F3/9

Altman Z-7.05

Beneish M0.22